Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect

Updated on: June 25,2024 7

Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect

Updated on:June 25,2024 7

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on: June 20,2024 6

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on:June 20,2024 6

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &

Updated on: June 20,2024 5

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &

Updated on:June 20,2024 5

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on: June 20,2024 8

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on:June 20,2024 8

New findings on hepatitis C in infants can lead to improved treatments

by Karolinska InstitutetElectron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.O

Updated on: June 17,2024 3

New findings on hepatitis C in infants can lead to improved treatments

by Karolinska InstitutetElectron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.O

Updated on:June 17,2024 3

Functional imaging shows how intestinal and liver diseases mutually influence each other

by Leibniz InstituteHistological inflammation of intestine improves the liver transplantation-free survival in PSC patients. a) Diagram of the study design for the PSC cohort. b) Kaplan–Meier survival

Updated on: June 17,2024 4

Functional imaging shows how intestinal and liver diseases mutually influence each other

by Leibniz InstituteHistological inflammation of intestine improves the liver transplantation-free survival in PSC patients. a) Diagram of the study design for the PSC cohort. b) Kaplan–Meier survival

Updated on:June 17,2024 4

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on: June 12,2024 7

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on:June 12,2024 7

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on: June 12,2024 3

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on:June 12,2024 3

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024 4

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024 4

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024 5

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024 5

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on: June 06,2024 6

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on:June 06,2024 6

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on: June 06,2024 3

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on:June 06,2024 3